Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).
Garcia-Donas J, Garrigos L, Lainez N, Santaballa A, Redondo A, Cueva JF, Rubio MJ, Prieto M, Lopez-Guerrero JA, Garcia-Casado Z, Barquin A, Grande E, Alia EG, Sevillano E, Bover I, Grazioso TP, Sanchez-Escribano R, Hurtado A, Navarro P, Rodriguez-Moreno JF.
Garcia-Donas J, et al. Among authors: grande e.
Clin Transl Oncol. 2024 Dec 30. doi: 10.1007/s12094-024-03827-4. Online ahead of print.
Clin Transl Oncol. 2024.
PMID: 39738931